Induced Pluripotent Stem Cell (iPSC) Market Size Report 2024-2032

Induced Pluripotent Stem Cell (iPSC) Market Share, Size, Trends, Industry Analysis Report, By Derived Cell (Hepatocytes, Fibroblasts, Neural Cells, Amniotic Cells, Cardiomyocytes, Others); By Workflow; By Application; By Region; Segment Forecast, 2024 - 2032

Published Date:May-2024
Pages: 118
Format: PDF
Report ID: PM2014
Base Year: 2023
Historical Data: 2019-2022

Report Outlook

healthcare refers to the organized services and systems designed to maintain and improve people's health. It includes prevention, diagnosis, treatment, and recovery, delivered by professionals like doctors, nurses, and medical specialists.

FAQ's

What is the expected industry size of induced pluripotent stem cell (iPSC) market?

Induced Pluripotent Stem Cell (iPSC) Market Size Worth USD 4,355.56 Million by 2032

Who are the top market players in the market?

Key players in the induced pluripotent stem cell (iPSC) market are Astellas Pharma Inc., Axol Bioscience Ltd., Cynata Therapeutics Limited, Fate Therapeutics

Which region contribute notably towards the global induced pluripotent stem cell (iPSC) market?

North America contribute notably towards the global induced pluripotent stem cell (iPSC) market.

What will be the expected CAGR of induced pluripotent stem cell (iPSC) market during the forecast period (2024-2032)

Induced Pluripotent Stem Cell (iPSC) market exhibiting the CAGR of 9.4% during the forecast period.

What are the key segments in the induced pluripotent stem cell (iPSC) market?

The induced pluripotent stem cell (iPSC) market report covering key segments are derived cell, workflow, application, and region

1. Introduction
              1.1. Report Description
                    1.1.1. Objectives of the Study
                    1.1.2. Market Scope
                    1.1.3. Assumptions
              1.2. Stakeholders
2. Executive Summary
              2.1. Market Highlights
3. Research Methodology
              3.1. Overview
                    3.1.1. Data Mining
              3.2. Data Sources
                    3.2.1. Primary Sources
                    3.2.2. Secondary Sources
4. Global Induced Pluripotent Stem Cell (iPSC) Market Insights
              4.1. Induced Pluripotent Stem Cell (iPSC) Market – Workflow Snapshot
              4.2. Induced Pluripotent Stem Cell (iPSC) Market Dynamics
                    4.2.1. Drivers and Opportunities
                            4.2.1.1. Increasing demand for body reconstruction procedures and tissue engineering
                            4.2.1.2. Rising Demand for Vaccine Production, Artificial Organs, Media, and Biopharmaceuticals
                                                4.2.1.2.1.1.1. Restraints and Challenges
                            4.2.1.3. Ethical Concerns Pertaining to Animals
                                  4.2.1.3.1. Porter’s Five Forces Analysis
                    4.2.2. Bargaining Power of Suppliers (Moderate)
                    4.2.3. Threats of New Entrants: (Low)
                    4.2.4. Bargaining Power of Buyers (Moderate)
                    4.2.5. Threat of Substitute (Moderate)
                    4.2.6. Rivalry among existing firms (High)
              4.3. PESTEL Analysis
              4.4. Induced Pluripotent Stem Cell (iPSC) Market Workflow Trends
              4.5. Value Chain Analysis
              4.6. COVID-19 Impact Analysis
5. Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell
              5.1. Key Findings
              5.2. Introduction
                    5.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
              5.3. Hepatocytes
                    5.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Hepatocytes, by Region, 2019-2032 (USD Million)
              5.4. Fibroblasts
                    5.4.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Fibroblasts, by Region, 2019-2032 (USD Million)
              5.5. Neural Cells
                    5.5.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Neural Cells, by Region, 2019-2032 (USD Million)
                    5.5.2. Excitatory Neurons
                            5.5.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Excitatory Neurons, by Region, 2019-2032 (USD Million)
                    5.5.3. Inhibitory Neurons
                            5.5.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Inhibitory Neurons, by Region, 2019-2032 (USD Million)
              5.6. Amniotic Cells
                    5.6.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Amniotic Cells, by Region, 2019-2032 (USD Million)
              5.7. Cardiomyocytes
                    5.7.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Cardiomyocytes, by Region, 2019-2032 (USD Million)
              5.8. Others
                    5.8.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Induced Pluripotent Stem Cell (iPSC) Market, by Application
              6.1. Key Findings
              6.2. Introduction
                    6.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
              6.3. Manufacturing
                    6.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Manufacturing, by Region, 2019-2032 (USD Million)
              6.4. Academic Research
                    6.4.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Academic Research, by Region, 2019-2032 (USD Million)
              6.5. Drug Development & Discovery
                    6.5.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Drug Development & Discovery, by Region, 2019-2032 (USD Million)
              6.6. Toxicity Screening
                    6.6.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Toxicity Screening, by Region, 2019-2032 (USD Million)
              6.7. Regenerative Medicine
                    6.7.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Regenerative Medicine, by Region, 2019-2032 (USD Million)
7. Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow
              7.1. Key Findings
              7.2. Introduction
                    7.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
              7.3. Reprogramming
                    7.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Reprogramming, By Region, 2019-2032 (USD Million)
              7.4. Cell Culture
                    7.4.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Cell Culture, By Region, 2019-2032 (USD Million)
              7.5. Cell Characterization / Analysis
                    7.5.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Cell Characterization / Analysis, By Region, 2019-2032 (USD Million)
              7.6. Engineering
                    7.6.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Engineering, By Region, 2019-2032 (USD Million)
              7.7. Others
                    7.7.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Others, By Region, 2019-2032 (USD Million)
8. Global Induced Pluripotent Stem Cell (iPSC) Market, by Geography
              8.1. Key findings
              8.2. Introduction
                    8.2.1. Induced Pluripotent Stem Cell (iPSC) Market Assessment, By Geography, 2019-2032 (USD Million)
              8.3. Induced Pluripotent Stem Cell (iPSC) Market – North America
                    8.3.1. North America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                    8.3.2. North America: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                    8.3.3. North America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.3.4. Induced Pluripotent Stem Cell (iPSC) Market – U.S.
                                          8.3.4.1. U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                          8.3.4.2. U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                                          8.3.4.3. U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.3.5. Induced Pluripotent Stem Cell (iPSC) Market – Canada
                            8.3.5.1. Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.3.5.2. Canada.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.3.5.3. Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
              8.4. Induced Pluripotent Stem Cell (iPSC) Market – Europe
                    8.4.1. Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                            8.4.2. Europe.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                    8.4.3. Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.4.4. Induced Pluripotent Stem Cell (iPSC) Market – UK
                            8.4.4.1. UK: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.4.4.2. UK.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.4.4.3. UK: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.4.5. Induced Pluripotent Stem Cell (iPSC) Market – France
                            8.4.5.1. France: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.4.5.2. France.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.4.5.3. France: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.4.6. Induced Pluripotent Stem Cell (iPSC) Market – Germany
                            8.4.6.1. Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.4.6.2. Germany.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.4.6.3. Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.4.7. Induced Pluripotent Stem Cell (iPSC) Market – Italy
                            8.4.7.1. Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.4.7.2. Italy.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.4.7.3. Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.4.8. Induced Pluripotent Stem Cell (iPSC) Market – Spain
                            8.4.8.1. Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.4.8.2. Spain.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.4.8.3. Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.4.9. Induced Pluripotent Stem Cell (iPSC) Market – Netherlands
                            8.4.9.1. Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.4.9.2. Netherlands.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.4.9.3. Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.4.10. Induced Pluripotent Stem Cell (iPSC) Market – Russia
                            8.4.10.1. Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.4.10.2. Russia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.4.10.3. Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
              8.5. Induced Pluripotent Stem Cell (iPSC) Market – Asia Pacific
                    8.5.1. Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                    8.5.2. Asia Pacific.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                    8.5.3. Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.5.4. Induced Pluripotent Stem Cell (iPSC) Market – China
                            8.5.4.1. China: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.5.4.2. China.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.5.4.3. China: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.5.5. Induced Pluripotent Stem Cell (iPSC) Market – India
                            8.5.5.1. India: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.5.5.2. India.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.5.5.3. India: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.5.6. Induced Pluripotent Stem Cell (iPSC) Market – Malaysia
                            8.5.6.1. Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.5.6.2. Malaysia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.5.6.3. Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.5.7. Induced Pluripotent Stem Cell (iPSC) Market – Japan
                            8.5.7.1. Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.5.7.2. Japan.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.5.7.3. Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.5.8. Induced Pluripotent Stem Cell (iPSC) Market – Indonesia
                            8.5.8.1. Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.5.8.2. Indonesia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.5.8.3. Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.5.9. Induced Pluripotent Stem Cell (iPSC) Market – South Korea
                            8.5.9.1. South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                            8.5.9.2. South Korea.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.5.9.3. South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
              8.6. Induced Pluripotent Stem Cell (iPSC) Market – Middle East & Africa
                    8.6.1. Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                    8.6.2. Middle East & Africa.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                    8.6.3. Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.6.4. Induced Pluripotent Stem Cell (iPSC) Market – Saudi Arabia
                            8.6.4.1. Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                            8.6.4.2. Saudi Arabia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.6.4.3. Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.6.5. Induced Pluripotent Stem Cell (iPSC) Market – UAE
                            8.6.5.1. UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.6.5.2. UAE.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.6.5.3. UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.6.6. Induced Pluripotent Stem Cell (iPSC) Market – Israel
                            8.6.6.1. Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.6.6.2. Israel.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.6.6.3. Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.6.7. Induced Pluripotent Stem Cell (iPSC) Market – South Africa
                            8.6.7.1. South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                            8.6.7.2. South Africa.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.6.7.3. South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
              8.7. Induced Pluripotent Stem Cell (iPSC) Market – Latin America
                    8.7.1. Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                    8.7.2. Latin America.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                    8.7.3. Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.7.4. Induced Pluripotent Stem Cell (iPSC) Market – Mexico
                            8.7.4.1. Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.7.4.2. Mexico.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.7.4.3. Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.7.5. Induced Pluripotent Stem Cell (iPSC) Market – Brazil
                            8.7.5.1. Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.7.5.2. Brazil.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.7.5.3. Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
                    8.7.6. Induced Pluripotent Stem Cell (iPSC) Market – Argentina
                            8.7.6.1. Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
                                  8.7.6.2. Argentina.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
                            8.7.6.3. Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
9. Competitive Landscape
              9.1. Expansion and Acquisition Analysis
                    9.1.1. Expansion
                    9.1.2. Acquisitions
              9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
              10.1. Astellas Pharma Inc
                    10.1.1. Company Overview
                    10.1.2. Financial Performance
                    10.1.3. Product Benchmarking
                    10.1.4. Recent Development
              10.2. Axol Bioscience Ltd
                    10.2.1. Company Overview
                    10.2.2. Financial Performance
                    10.2.3. Product Benchmarking
                    10.2.4. Recent Development
              10.3. Cynata Therapeutics Limited
                    10.3.1. Company Overview
                    10.3.2. Financial Performance
                    10.3.3. Product Benchmarking
                    10.3.4. Recent Development
              10.4. Fate Therapeutics
                    10.4.1. Company Overview
                    10.4.2. Financial Performance
                    10.4.3. Product Benchmarking
                    10.4.4. Recent Development
              10.5. FUJIFILM Holdings Corporation (Cellular Dynamics)
                    10.5.1. Company Overview
                    10.5.2. Financial Performance
                    10.5.3. Product Benchmarking
                    10.5.4. Recent Development
              10.6. Ncardia
                    10.6.1. Company Overview
                    10.6.2. Financial Performance
                    10.6.3. Product Benchmarking
                    10.6.4. Recent Development
              10.7. REPROCELL Inc.
                    10.7.1. Company Overview
                    10.7.2. Financial Performance
                    10.7.3. Product Benchmarking
                    10.7.4. Recent Development
              10.8. Takara Bio Inc.
                    10.8.1. Company Overview
                    10.8.2. Financial Performance
                    10.8.3. Product Benchmarking
                    10.8.4. Recent Development
              10.9. Thermo Fisher Scientific Inc.
                    10.9.1. Company Overview
                    10.9.2. Financial Performance
                    10.9.3. Product Benchmarking
                    10.9.4. Recent Development
              10.10. ViaCyte, Inc
                    10.10.1. Company Overview
                    10.10.2. Financial Performance
                    10.10.3. Product Benchmarking
                    10.10.4. Recent Development

List of Tables

Table 1 Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 2 Global Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 3 Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 4 Induced Pluripotent Stem Cell (iPSC) Market Assessment, By Geography, 2019-2032 (USD Million)
Table 5 North America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 6 North America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 7 North America: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 8 U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 9 U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 10 U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 11 Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 12 Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 13 Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 14 Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 15 Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 16 Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 17 UK: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 18 UK: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 19 UK: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 20 France: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 21 France: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 22 France: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 23 Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 24 Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 25 Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 26 Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 27 Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 28 Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 29 Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 30 Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 31 Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 32 Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 33 Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 34 Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 35 Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 36 Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 37 Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 38 Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 39 Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 40 Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 41 China: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 42 China: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 43 China: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 44 India: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 45 India: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 46 India: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 47 Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 48 Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 49 Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 50 Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 51 Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 52 Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 53 Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 54 Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 55 Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 56 South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 57 South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 58 South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 59 Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 60 Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 61 Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 62 Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 63 Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 64 Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 65 UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 66 UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 67 UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 68 Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 69 Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 70 Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 71 South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 72 South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 73 South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 74 Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 75 Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 76 Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 77 Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 78 Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 79 Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 80 Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 81 Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 82 Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 83 Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 84 Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 85 Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)

List of Figures

Figure 1. Global Induced Pluripotent Stem Cell (iPSC) Market, 2019-2032 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter’s Five Forces
Figure 6. Market by Application
Figure 7. Global Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2023-2032 (USD Million)
Figure 8. Market by Derived Cell
Figure 9. Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2023-2032 (USD Million)
Figure 10. Market by Workflow
Figure 11. Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2023-2032 (USD Million)
Figure 12. Induced Pluripotent Stem Cell (iPSC) Market Assessment, By Geography, 2019-2032 (USD Million)
Figure 13. Strategic Analysis – Induced Pluripotent Stem Cell (iPSC) Market

Report Scope

Induced Pluripotent Stem Cell (iPSC) Market, Derived Cell Outlook (Revenue - USD Billion, 2019-2032)

Hepatocytes
Fibroblasts
Neural Cells
- Excitatory Neurons
- Inhibitory Neurons
Amniotic Cells
Cardiomyocytes
Others

Induced Pluripotent Stem Cell (iPSC) Market, Application Outlook (Revenue - USD Billion, 2019-2032)

Manufacturing
Academic Research
Drug Development & Discovery
Toxicity Screening
Regenerative Medicine

Induced Pluripotent Stem Cell (iPSC) Market, Workflow Outlook (Revenue - USD Billion, 2019-2032)

Reprogramming
Cell Culture
Cell Characterization / Analysis
Engineering
Others

Induced Pluripotent Stem Cell (iPSC) Market, Regional Outlook (Revenue - USD Billion, 2019-2032)

North America
- Derived Cell Outlook
  - Hepatocytes
  - Fibroblasts
  - Neural Cells
    - Excitatory Neurons
    - Inhibitory Neurons
  - Amniotic Cells
  - Cardiomyocytes
  - Others
- Application Outlook
  - Manufacturing
  - Academic Research
  - Drug Development & Discovery
  - Toxicity Screening
  - Regenerative Medicine
- Workflow Outlook
  - Reprogramming
  - Cell Culture
  - Cell Characterization / Analysis
  - Engineering
  - Others
Europe
- Derived Cell Outlook
  - Hepatocytes
  - Fibroblasts
  - Neural Cells
    - Excitatory Neurons
    - Inhibitory Neurons
  - Amniotic Cells
  - Cardiomyocytes
  - Others
- Application Outlook
  - Manufacturing
  - Academic Research
  - Drug Development & Discovery
  - Toxicity Screening
  - Regenerative Medicine
- Workflow Outlook
  - Reprogramming
  - Cell Culture
  - Cell Characterization / Analysis
  - Engineering
  - Others
Asia Pacific
- Derived Cell Outlook
  - Hepatocytes
  - Fibroblasts
  - Neural Cells
    - Excitatory Neurons
    - Inhibitory Neurons
  - Amniotic Cells
  - Cardiomyocytes
  - Others
- Application Outlook
  - Manufacturing
  - Academic Research
  - Drug Development & Discovery
  - Toxicity Screening
  - Regenerative Medicine
- Workflow Outlook
  - Reprogramming
  - Cell Culture
  - Cell Characterization / Analysis
  - Engineering
  - Others
Latin America
- Derived Cell Outlook
  - Hepatocytes
  - Fibroblasts
  - Neural Cells
    - Excitatory Neurons
    - Inhibitory Neurons
  - Amniotic Cells
  - Cardiomyocytes
  - Others
- Application Outlook
  - Manufacturing
  - Academic Research
  - Drug Development & Discovery
  - Toxicity Screening
  - Regenerative Medicine
- Workflow Outlook
  - Reprogramming
  - Cell Culture
  - Cell Characterization / Analysis
  - Engineering
  - Others
Middle East & Africa
- Derived Cell Outlook
  - Hepatocytes
  - Fibroblasts
  - Neural Cells
    - Excitatory Neurons
    - Inhibitory Neurons
  - Amniotic Cells
  - Cardiomyocytes
  - Others
- Application Outlook
  - Manufacturing
  - Academic Research
  - Drug Development & Discovery
  - Toxicity Screening
  - Regenerative Medicine
- Workflow Outlook
  - Reprogramming
  - Cell Culture
  - Cell Characterization / Analysis
  - Engineering
  - Others

Quantitative Analysis

Market size, estimates, and forecasts from 2019-2032
Market size and revenue estimates for derived Cell up to 2032
Market revenue estimates for application up to 2032
Market revenue estimates for workflow up to 2032
Regional market size and forecast up to 2032
Company financials

Request Free Sample

Please fill out the form to receive sample pages of the report.

We take great pride in "Delivering game-changing business opportunities reports with report customizations", so please don't hesitate to share with us your unique interests and business difficulties in much more detail.

By using this form you agree with the storage and handling of your data by this website.

This website is secure and your personal details are safe. Privacy Policy

Induced Pluripotent Stem Cell (iPSC) Market Size Report 2024-2032

What's Included in Full Report?

Request Sample Report